Anticipating the "silver tsunami": Prevalence trajectories and comorbidity burden among older cancer survivors in the United States

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 7, 2016, Pages 1029-1036

  Bluethmann, Shirley M ^a   Mariotto, Angela B ^a   Rowland, Julia H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; AGING; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CANCER SURVIVOR; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORECTAL CANCER; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HEMIPLEGIA; HUMAN; KIDNEY DISEASE; LEUKEMIA; LIVER DYSFUNCTION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICARE; MIDDLE AGED; MILD HEPATIC IMPAIRMENT; MODERATE HEPATIC IMPAIRMENT; MOUTH CANCER; NEOPLASM; PARAPLEGIA; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RHEUMATIC DISEASE; SEVERE HEPATIC IMPAIRMENT; ULCER; UNITED STATES; VERY ELDERLY; AGE; AGE DISTRIBUTION; HEALTH SURVEY; INCIDENCE; RISK; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVOR;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; CANCER SURVIVORS; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; POPULATION SURVEILLANCE; PREVALENCE; RISK; SEER PROGRAM; SEX DISTRIBUTION; SURVIVORS; UNITED STATES;

EID: 84977109186     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0133     Document Type: Article

References (51)

1. Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev 2011;20:1996-2005
2. Frey WH. Baby boomers and the new demographics of america's seniors. Generations 2010;34:28-37
3. de Moor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev 2013;22:561-70
4. Levit L, Balogh E, Nass S, Ganz PA. Delivering high-quality cancer care: charting a new course for a system in crisis. Washington, DC: Institute of Medicine; 2013
5. Rowland JH, Bellizzi KM. Cancer survivorship issues: life after treatment and implications for an aging population. J Clin Oncol 2014;32:2662-8
6. Leach CR, Weaver KE, Aziz NM, Alfano CM, Bellizzi KM, Kent EE, et al. The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv 2014;9:239-51
7. Bellizzi KM, Aziz NM, Rowland JH, Weaver K, Arora NK, Hamilton AS, et al. Double jeopardy? age, race, and HRQOL in older adults with cancer. J Cancer Epidemiol 2012;2012:478642
8. Hurria A, Levit LA, Dale W, Mohile SG,Muss HB, Fehrenbacher L, et al. Improving the evidence base for treating older adults with cancer: American society of clinical oncology statement. J Clin Oncol 2015; 33:3826-33
9. Hewitt M, Rowland JH, Yancik R. Cancer survivors in the united states: age, health, and disability. J Gerontol A Biol Sci Med Sci 2003;58:M82-91
10. Rowland JH, Yancik R. Cancer survivorship: the interface of aging, comorbidity, and quality care. J Natl Cancer Inst 2006;98:504-5
11. Bartels SJ, Naslund JA. The underside of the silver tsunami-older adults and mental health care. N Engl J Med 2013;368:493-6
12. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009;27:2758-65
13. Verdecchia A, Angelis GD, Capocaccia R. Estimation and projections of cancer prevalence from cancer registry data. Stat Med 2002;21:3511-26
14. Mariotto AB, Yabroff KR, Feuer EJ, De Angelis R, Brown M. Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020. Cancer Causes Control 2006;17:1215-26
15. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the united states: 2010-2020. J Natl Cancer Inst 2011;103:117-28
16. Colby SL, Ortman JM (U.S. Census Bureau, Washington, DC). Washington, DC: US Census Bureau; 2014 Mar. Report No.: P25-1143
17. Howlader N, Noone A, Krapcho M. SEER Cancer Statistics Review, 1975-2012, National Cancer Institute; 2015. Available from: http://seer.cancer. gov/csr/1975-2013
18. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 2002;40:IV3-IV18
19. Surveillance Research Program, National Cancer Institute SEER Stat software version 8.2.1. Avaialble from: www.seer.cancer.gov/seerstat
20. Yu B, Tiwari RC, Cronin KA, Feuer EJ. Cure fraction estimation from the mixture cure models for grouped survival data. Stat Med 2004; 23:1733-47
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
22. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53:1258-67
23. Klabunde CN, Legler JM, Warren JL, Baldwin L, Schrag D. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 2007;17: 584-90
24. Mariotto AB, Wang Z, Klabunde CN, Cho H, Das B, Feuer EJ. Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients. J Clin Epidemiol 2013; 66:1376-85
25. Cho H, Klabunde CN, Yabroff KR, Wang Z, Meekins A, Lansdorp-Vogelaar I, et al. Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med 2013;159:667-76
26. Garman KS, Pieper CF, Seo P, Cohen HJ. Function in elderly cancer survivors depends on comorbidities. J Gerontol A Biol Sci Med Sci 2003;58:M1119-24
27. Cho H, Mariotto AB, Mann BS, Klabunde CN, Feuer EJ. Assessing noncancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence. Am J Epidemiol 2013;178:339-49
28. Edwards BK, Howe HL, Ries LAG, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002;94: 2766-92
29. Yancik R. Population aging and cancer: a cross-national concern. Cancer J 2005;11:437-41
30. Townsley CA, Selby R, Siu LL. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 2005;23:3112-24
31. Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin 2010;60:120-32
32. Puts MTE, Santos B, Hardt J, Monette J, Girre V, Atenafu EG, et al. An update on a systematic review of the use of geriatric assessment for older adults in oncology. Ann Oncol 2014;25:307-15
33. Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen MLG, Extermann M, et al. International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 2014;32: 2595-603
34. Walko CM, McLeod HL. Personalizing medicine in geriatric oncology. J Clin Oncol 2014;32:2581-6
35. Sprod LK, Mohile SG, Demark-Wahnefried W, Janelsins MC, Peppone LJ, Morrow GR, et al. Exercise and cancer treatment symptoms in 408 newly diagnosed older cancer patients. J Geriatr Oncology 2012; 3:90-7
36. Bluethmann SM, Basen-Engquist K, Vernon SW, Cox M, Gabriel KP, Stansberry SA, et al. Grasping the 'teachable moment': time since diagnosis, symptom burden and health behaviors in breast, colorectal and prostate cancer survivors. Psychooncology 2015;24:1250-7
37. Hurria A. Management of elderly patients with cancer. J Natl Compr Canc Netw 2013;11:698-701
38. Naeim A, AaproM, Subbarao R, Balducci L. Supportive care considerations for older adults with cancer. J Clin Oncol 2014;32:2627-34
39. Cohen HJ. Functional assessment and the cancer survivor: something old, something new. J Natl Cancer Inst 2010;102:1450-1
40. Hurria A, Mohile SG, Dale W. Research priorities in geriatric oncology: addressing the needs of an aging population. J Natl Compr Canc Netw 2012;10:286-8
41. Hubbard JM, Cohen HJ, Muss HB. Incorporating biomarkers into cancer and aging research. J Clin Oncol 2014;32:2611-6
42. Nekhlyudov L, Aziz NM, Lerro C, Virgo KS. Oncologists' and primary care physicians' awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors. J Oncol Pract 2014;10:e29-36
43. Howlader N, Mariotto AB, Woloshin S, Schwartz LM. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death. J Natl Cancer Inst Monogr 2014;2014: 255-64
44. Chubak J, Tuzzio L, Hsu C, Alfano CM, Rabin BA, Hornbrook MC, et al. Providing care for cancer survivors in integrated health care delivery systems: practices, challenges, and research opportunities. J Oncol Pract 2012;8:184-9
45. Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. The expanding role of primary care in cancer control. Lancet Oncol 2015;16:1231-72
46. Yabroff KR, Kim Y. Time costs associated with informal caregiving for cancer survivors. Cancer 2009;115:4362-73
47. Romito F, Goldzweig G, Cormio C, Hagedoorn M, Andersen BL. Informal caregiving for cancer patients. Cancer 2013;119:2160-9
48. National Caregiving Alliance and American Association of Retired Persons. Caregiving in the U.S. Bethesda, MD: National Caregiving Alliance; 2015
49. Kent EE, Rowland JH, Northouse L, Litzelman K, Chou WS, Shelburne N, et al. Caring for caregivers and patients: research and clinical priorities for informal cancer caregiving. Cancer 2016 Mar 17. [Epub ahead of print]
50. Moy B, Flaig TW, Muss HB, Clark B, Tse W, Windham TC. Geriatric oncology for the 21st century: a call for action. J Oncol Pract 2014;10: 241-3
51. Stanton AL, Ganz PA, Rowland JH, Meyerowitz BE, Krupnick JL, Sears SR. Promoting adjustment after treatment for cancer. Cancer 2005;104: 2608-13